New Report Focussed on on Innovative Licensing Opportunities in Non-Hodgkin Lymphoma
- Written by Pitch Engine
Frontier Pharma: Innovative Licensing Opportunities in Non-Hodgkin Lymphoma is a new market research publication announced by Reportstack. Non-Hodgkin Lymphoma (NHL) can be seen as a collection of up to 60 smaller subtypes of malignant lymphoid disease, defined by distinct morphological, cytogenetic and immunophenotypic characteristics...
Read more: New Report Focussed on on Innovative Licensing Opportunities in Non-Hodgkin Lymphoma

